Artificially Cloaked Viral Nanovaccine for Cancer Immunotherapy

Nature Communications - United Kingdom
doi 10.1038/s41467-019-13744-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Viral Vectors for Cancer Immunotherapy

Frontiers in Bioscience - Landmark
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2006English

Non‐viral Gene Delivery for Cancer Immunotherapy

Journal of Gene Medicine
Molecular MedicineDrug DiscoveryGeneticsMolecular Biology
2019English

A Bi-Adjuvant Nanovaccine That Potentiates Immunogenicity of Neoantigen for Combination Immunotherapy of Colorectal Cancer

Science advances
Multidisciplinary
2020English

Immunotherapy for Viral and Fungal Infections

Bone Marrow Transplantation
TransplantationHematology
2015English

Immunotherapy for Gastrointestinal Cancer

Gastroenterology
HepatologyGastroenterology
2019English

Immunotherapy for Cervical Cancer

BioDrugs
MedicineBiotechnologyPharmacology
2010English

Moving Cancer Immunotherapy Forward Through the Journal for ImmunoTherapy of Cancer (JITC)

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

Targeting Adenosine for Cancer Immunotherapy

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2018English

Engineering Anti-Cancer Nanovaccine Based on Antigen Cross-Presentation

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy